All The News, All In One Place
Pranav Birje | The News Bulletins The first part of Sade Made Teen remains unforgettable in Marathi cinema…
Read MorePranav Birje | The News Bulletins MRK Motorcycle Training, founded by Rohan Mhatre on May 23, 2019, has…
Read MorePranav Birje | The News Bulletins Today at the grand event of upcoming pan-india spectacle Mirai, when actor…
Read MorePranav Birje | The News Bulletins Pune, 04, September 2025- In a strategic move to bridge the gap…
Read MorePranav Birje | The News Bulletins Netflix and Applause Entertainment reunite for ‘The Game: You Never Play Alone’,…
Read MorePranav Birje | The News Bulletins Panaji, September 3, 2025: The Public Relations Council of India (PRCI) –…
Read MorePranav Birje| The News Bulletins National 3rd September 2025: – DP World’s $2.5bn investment in developing end-to-end logistics…
Read MorePranav Birje| The News Bulletins Mumbai, September 2025: KT Professional, one of India’s fastest-growing professional haircare brands, has…
Read MorePranav Birje| The News Bulletins ● More than 36,021 individuals have been positively impacted, including adolescent girls and…
Read MorePranav Birje | The News Bulletins As Bastian Bandra, the flagship that started it all, bids adieu, the…
Read More• 15-ft modak made with 1,000+ Gemini Sunflower Oil bottles, weighing over 1500 kgs, becomes a major festive…
Read MoreNew Delhi, September 3, 2025: Axis Max Life Insurance Limited (“Axis Max Life”/ “Company), formerly known as Max…
Read MorePranav Birje | The News Bulletins Bengaluru, 28th August, 2025 — Curefoods, Bangalore-based, internet-driven multi-brand food services company,…
Read MorePranav Birje | The News Bulletins Mumbai, India: In a beauty market crowded with repurposed Western formulas, R.O.A…
Read MorePranav Birje| The News Bulletins The much-awaited Marathi film “Sakaal Tar Hou Dya”, presented by Shrey Picture Company…
Read MorePranav Birje| The News Bulletins Achieves 15% higher emission reductions YoY with 188,507 tCO2e reductions in the…
Read MorePranav Birje | Senior Correspondent • Jemperli (dostarlimab) is India’s first and only approved PD-1 immunotherapy for second-line…
Read More